João Silva concluded his degree in Biotechnology (average grade of 14) in 2020 from the University of Beira Interior (UBI), with his final project entitled "Squid-Inspired Tandem Repeat Proteins: Design, Synthesis and Nanoparticles formulation for Cancer Drug Delivery" delving into the fields of proteomics and cancer drug delivery. In 2022, he completed his master's in Biotechnology, by developing and optimizing a novel purification workflow based on the integration of a simple gellan gum batch method with co-immunoprecipitation for the capture and purification of STEAP1, with an overall grade in the excellent range (18). During his dissertation year, he was awarded an FCT-funded scientific initiation scholarship encompassed in the Multidisciplinary Experience in Research to fight Cancer and Infection (MERCI-BII4) project and in line with his research topic, culminating in the presence of the "Verão com Ciência" round table, discussing outlooks into the scientific and research fields, as well as incentives and challenges faced. Recently, João has started his doctoral program in Biomedicine at UBI and was awarded in March of 2023 the UBI-Santander (FCS) doctoral incentive scholarship (5 months) to research potential inhibitors for the STEAP1 protein. In the latest year, he has contributed two articles to the scientific field, in high impact factor international journals. An original article comprising the outputs of his master's project entitled "Specific Six-Transmembrane Epithelial Antigen of the Prostate 1 Capture with Gellan Gum Microspheres: Design, Optimization and Integration" in International Journal of Molecular Sciences (Impact factor: 6.208; Q1 from Biochemistry & Molecular Biology; https://doi.org/10.3390/ijms24031949), and a review article entitled "Progress and emerging opportunities of application of the gellan gum biopolymer" in Carbohydrate Polymers (Impact factor: 10.723; D1 (3/90) from Polymer Science; https://doi.org/10.1016/j.carbpol.2023.120782). Moreover, he has presented a poster in an international conference (Biopartitioning & Purification Conference 2022) and holds an oral communication in the XVII CICS-UBI Symposium. He acted as a monitor for a student in the seminar discipline in the biomedical sciences bachelors at UBI, exploring the potential of marine compounds as STEAP1 ligands through molecular docking. Moreover, he has been heavily focused on self-learning, through e-learning platforms, and has delved into and acquired knowledge in the areas of bioinformatics and data science (e.g., python, bash, machine learning, among others), computational drug discovery (e.g., molecular docking and molecular dynamics) and differential gene expression (e.g., qRT-PCR and RNAseq pipelines). Recently, he is an investigator in the ongoing project "ONCOSENSING" from the PROMOVE contest, awarded by Fundação "la Caixa", developing a detection method for the E7 protein in HPV, responsible for cervical cancer.